Year All202620252024202320222021 6/15/2026 Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update Read More 5/12/2026 Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference Read More 5/7/2026 Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More 4/6/2026 Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference Read More 3/30/2026 Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Read More 3/16/2026 Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026 Read More 2/4/2026 Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 Read More 1/5/2026 Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones Read More 1/5/2026 Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation Read More
6/15/2026 Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update Read More
5/12/2026 Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference Read More
5/7/2026 Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More
4/6/2026 Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference Read More
3/30/2026 Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Read More
3/16/2026 Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026 Read More
2/4/2026 Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 Read More
1/5/2026 Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones Read More
1/5/2026 Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation Read More
